Hepatocellular carcinoma (HCC) is one of the most frequently encountered malignancies. Distant metastasis is a common sequela, occurring in approximately 50% of cases. Metastasis to the oral cavity is very rare. Careful immunohistochemical evaluation is critical in diff erentiating HCC from other metastatic malignancies. An understanding of the possibility that HCC may initially present as a mandibular metastasis is crucial to guide management. We describe the case of a 76-year-old man with a 3-to 4-month history of a painless, slowly enlarging, left -sided jaw mass. Biopsy fi ndings were consistent with HCC. While the patient was a known hepatitis C carrier, the presence of HCC had been previously unknown. Additional workup revealed a large hepatic lesion. In view of his poor health, the patient elected to forgo chemotherapy, and he entered a hospice facility. Th is case provides an illustration that an isolated mandibular mass may represent the initial presentation of HCC. Subsequent identifi cation of the primary tumor via radiographic and pathologic evaluations is important for the guidance of further management.
Introduction
Approximately 1 million new cases of hepatocellular carcinoma (HCC) are diagnosed worldwide every year. 1 HCC metastasizes in about 50% of cases, most oft en to the lungs, abdominal lymph nodes, diaphragm, adrenal glands, and skeleton. 2 HCC metastases to the oral cavity and mandible are very rare. 3 Overall, only 1 to 3% of all malignancies in the oral cavity are metastatic in origin; of these, the most common distant primary sites are the breast, lung, adrenal glands, prostate, and kidney. 4 We report a new case of HCC metastatic to the mandible. We review the clinical, immunohistochemical, and radiologic fi ndings in this case, and we discuss the diagnostic approaches we used to identify the metastatic HCC.
Case report
A 76-year-old man was referred to our ENT Department with a slowly growing, left -sided parasymphyseal mandibular mass of 3 to 4 months' duration. He had failed to improve aft er taking two courses of antibiotics prescribed by his dentist. Physical examination revealed a painless, 6-cm mandibular mass with associated numbness of the left lower lip and chin. His medical history was signifi cant for hepatitis C virus infection and chronic alcohol use.
An open biopsy of the mass was performed, and microscopic evaluation revealed sheets and irregular groupings of large polygonal cells with irregular hyperchromatic nuclei and moderately abundant, clear to eosinophilic cytoplasm. Immunohistochemical analysis revealed that the specimen was positive for cytokeratin, MOC31, OCH1E5, and thyroid transcription factor 1 (TTF-1) (fi gure 1). Additional evaluation and staining were negative for vimentin; for the malignant melanoma markers S-100, A-103, and HMB-45; for renal cell carcinoma marker 66.4.C2; for leukocyte common antigen; for prostate-specifi c antigen; and for urothelial and breast carcinoma marker 34Be12. Th ese fi ndings confi rmed the diagnosis of metastatic HCC. Computed tomography (CT) of the head and neck demonstrated a destructive the patient elected to forgo chemotherapy. He entered a hospice facility, where he died of his disease.
Discussion
Metastasis of HCC to the oral cavity is very rare. When it does occur, the most frequently aff ected sites are the mandible and the gingiva. 3 Th e reason that the mandible is the most common site is probably because it contains hematopoietic tissue. 5 Th e diagnosis of HCC metastatic to the oral cavity can be diffi cult, especially when the primary tumor has not yet been discovered. (It is interesting that in 66% of all reported cases of HCC metastatic to the oral cavity, the lesion of the left mandible consistent with what was seen on examination (fi gure 2, A). CT of the lungs and abdomen showed several tiny, calcifi ed pulmonary nodules consistent with granulomatous disease and a large, ill-defi ned, heterogeneous hepatic-dome mass that was consistent with HCC (fi gure 2, B).
Th e hematology/oncology, radiation oncology, and dentistry services were consulted for assistance in the management of this patient. Laboratory test results revealed slight anemia, with a hematocrit value of 35.7% (range of normal: 40 to 54%). Testing also revealed slight elevations in coagulation parameters; the activated partial thromboplastin time (aPTT) was 43.3 seconds (normal: 19.5 to 38.5), the prothrombin time (PT) was 15.2 seconds (normal: 12.2 to 15.1), and the international normalized ratio (INR) was 1.2 (normal: 0.8 to 1.2). Liver function testing revealed an aspartate transaminase (AST) level of 53 U/L (normal: 5 to 34) and an alanine transaminase (ALT) concentration of 65 U/L (normal: 0 to 55).
A complete dental extraction was performed in preparation for radiation therapy. However, the extractions were complicated by signifi cant bleeding, which reduced the hematocrit value to 24.6% and necessitated repletion with blood products. Once the patient was stabilized, he underwent an uncomplicated course of radiation therapy to the mandible, and this resulted in a near-complete resolution of the mass. However, he later suff ered a pathologic fracture to his left femoral neck that required orthopedic intervention. In view of his poor general health, which included a poor cardiac status, oral metastasis was identifi ed before the primary lesion was. 6 ) Aff ected patients typically present with a painless, slowly growing mass within the mandibular ramus along with associated swelling and hypoesthesia. CT studies of the oral cavity typically demonstrate a radiolucent lesion with a destructive appearance and lacking defi ned borders and sclerotic limits. 7 Th e histopathologic appearance of HCC is characterized by trabecular groupings of large cells with clear to eosinophilic cytoplasm, occasionally in a lobule-like pattern. Since the appearance of breast, endocrine pancreas, kidney, and adrenal tumors may mimic that of HCC, immunohistochemical analysis is necessary for diff erentiation. Metastatic HCC is delineated by the presence of albumin, fi brinogen, α1-antitrypsin, and the expression of cytokeratins 8 and 18 and α-fetoprotein. 1 Recently, the introduction of antihepatocyte antibody (heppar-1), also known as OCH1E5 (Hepatocyte; Dako; Carpenteria, Calif.), has facilitated making the distinction between HCC and other metastatic tumors. 8 Heppar-1 binds to an antigen present on cells of hepatic origin, both benign and malignant. While heppar-1 is highly sensitive and specifi c for HCC, 9 additional immunohistochemical staining should be performed to ensure accuracy. 10 Cytoplasmic staining with TTF-1 in HCC has also been described. 11 Electron microscopy may demonstrate bile canaliculi. 1 In the case of our patient, the biopsy specimen was positive for cytokeratin as well as heppar-1 (OCH1E5), thereby confi rming the diagnosis of metastatic HCC.
Th e prognosis for patients with advanced HCC with distant metastatic disease is very poor. Most patients with oral metastatic HCC die within 2 years of the diagnosis of the oral tumor. 7 Local radiation therapy to the oral lesion and chemotherapy for control of the primary lesion are the most common modes of therapy used for palliation. Teshigawara et al described a patient in whom radical resection was undertaken to remove a mandibular metastasis while transcatheter arterial embolization was used to treat the primary tumor. 3 Th eir patient was recurrence-free 9 months aft er treatment. Although that patient was successfully treated with radical resection of the metastatic lesion, care must be taken to select appropriate patients in such circumstances. In view of the high vascularity of metastatic HCC tumors and the coagulopathy that oft en accompanies primary liver disease, a resection or even a biopsy can become complicated by problematic hemorrhage. Most bleeding can be controlled with hemostatic agents, wide sutures, or, as in the case of our patient, compression. 5, 7 In rare cases, hemorrhaging can be so severe that extensive procedures, such as external carotid artery ligation or embolization, become necessary. 5 Because of the severity of this complication, some authors suggest that if metastatic HCC is suspected, as in the case of an oral cavity mass, a fi ne-needle aspiration biopsy should be performed to confi rm the diagnosis. If the aspiration biopsy cannot confi rm the diagnosis, an open biopsy should be performed. 12 In summary, HCC metastatic to the oral cavity and jaw is very rare, but it should still be considered in the diff erential diagnosis of any patient who presents with a rapidly growing oral cavity or mandibular mass, especially a patient with a documented chronic hepatitis infection. Th e diagnosis requires immunohistochemical staining to rule out other primary or metastatic malignancies. Despite advances in medical treatment, patients with the diagnosis of HCC with metastatic disease to the oral cavity have a poor outcome.
